The DNA Thrombotic Risk Test is a genetic test designed to determine if you have an increased risk of developing blood clots, a condition known as thrombophilia. This test examines specific genetic variants that are associated with a higher likelihood of abnormal clotting. Here are some key points:
Key Genes Tested
-
F5 (Factor V Leiden): A mutation in this gene can increase the risk of deep vein thrombosis (DVT) and other clotting disorders.
-
F2 (Prothrombin): A mutation in this gene can also elevate the risk of blood clots.
-
MTHFR: Mutations in this gene can affect homocysteine levels, which can influence clotting risk.
Procedure
-
Sample Collection: The test typically involves a simple buccal swab (cheek swab) to collect DNA.
-
Analysis: The collected DNA is analyzed in a lab to identify the presence of the specific genetic variants.
Benefits
-
Risk Assessment: Helps identify individuals at higher risk for thrombophilia, allowing for early intervention and management.
-
Personalized Care: Provides valuable information for healthcare providers to tailor treatment and preventive measures.
Considerations
-
Genetic Predisposition: Having these genetic variants does not guarantee that you will develop blood clots, but it does indicate a higher risk.
-
Other Factors: Lifestyle, environmental factors, and other health conditions also play a significant role in clotting risk.
Contact DNA Consulta on (00356) 7979 7910 or send an email to novagia@hotmail.com to know more and book a test..